Gain Therapeutics, Inc. Quarterly Revenues in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Gain Therapeutics, Inc. annual/quarterly Revenues history and growth rate from Q1 2020 to Q1 2023.
  • Gain Therapeutics, Inc. Revenues for the quarter ending March 31, 2023 was $55.2K, a 22.6% increase year-over-year.
  • Gain Therapeutics, Inc. annual Revenues for 2023 was $55.2K, a 60.6% decline from 2022.
  • Gain Therapeutics, Inc. annual Revenues for 2022 was $140K, a 15.1% decline from 2021.
  • Gain Therapeutics, Inc. annual Revenues for 2021 was $165K, a 471% increase from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $55.2K +$10.2K +22.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q2 2022 $211K $95.1K +$5.93K +6.65% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $205K $45K +$39.7K +754% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $165K $43.2K +$34.1K +373% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $131K $27.3K +$20.6K +308% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $110K $89.2K +$82.8K +1299% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $27.5K $5.27K -$1.4K -21% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $28.9K $9.14K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 $6.7K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $6.37K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $6.67K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.